Characterizing Anxiety Among Individuals Receiving Treatment for Alcohol and Substance Use Disorders.
| Autor: | Domenico LH; 1 Lisa H. Domenico, PhD, University of Florida, Gainesville, FL, USA., Lewis B; 2 Ben Lewis, PhD, University of Florida, Gainesville, FL, USA., Hazarika M; 3 Mythili Hazarika, PhD, Gauhati Medical College Hospital, Guwahati, Assam, India., Nixon SJ; 4 Sara Jo Nixon, PhD, University of Florida, Gainesville, FL, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of the American Psychiatric Nurses Association [J Am Psychiatr Nurses Assoc] 2018 Jul/Aug; Vol. 24 (4), pp. 343-351. Date of Electronic Publication: 2017 Nov 10. |
| DOI: | 10.1177/1078390317739106 |
| Abstrakt: | Background: Despite high prevalence of generalized anxiety disorder (GAD) substance use disorder (SUD) comorbidity, little is known regarding demographic characteristics associated with GAD in SUD treatment seekers. Objective: To characterize demographic differences between inpatient SUD treatment seekers reporting varying levels of GAD symptomatology. Design: General linear models, chi-square test, t test, and correlational analyses were utilized to assess group differences. Groups included those with no history of significant anxiety (No GAD; n = 256), subclinical anxiety (Subclinical; n = 85), and those meeting GAD diagnostic criteria (GAD; n = 61). Results: The No GAD group differed substantially from Subclinical and GAD individuals. With the exception of polysubstance use, no differences were found regarding Subclinical and GAD groups. Conclusion: Individuals with subclinical GAD symptoms and those meeting diagnostic criteria were nearly identical regarding precursors to problematic substance use, severity of use, and key mental health indicators. Findings suggest subclinical levels of GAD should not be overlooked when assessing and treating SUDs. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|